AKTX

Akari Therapeutics, Plc

HealthcareBiotechnologyGBUSDPeers →Country macro →

$10.94

LiveJun 18, 2026

Market cap

$12.52M

52w range

3.02 – 49.60

P / E

—

EPS

—

Volume

67.38K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Akari Therapeutics, Plc’s valuation

○

Insider buys and sells are sourced from SEC Form 4 filings, which cover US-listed issuers. We don't have Form 4 history for this name.

Transactions

0 buys · 0 sells

Bought

Open market

Sold

Open market

Net flow

+$0

Buys − sells

Insider	Role	Action	Shares	Price	Value	Trade date	Filing
No open-market insider activity in this window.

13F position evolution

No 13F history in institutional_holders for AKTX-US.

Pro

Detailed insider buy/sell history is included with Pro.